# Example Clinical Company — value research

**FICTIONAL DEMO · SCENARIO_ONLY**

Cutoff: 2026-11-02T16:00:00Z · as\_observed · USD

## Business and material event

A fictional clinical-stage company with one candidate and future funding needs.

A product milestone may change the economics; this toy example does not model a clinical probability.

Resolution: No real event is forecast. Replace with a precise endpoint, deadline and primary-source rule for actual research.

Horizon: Illustrative present-value scenarios; no forecast holding period.

## What could it be worth?

All amounts are in the stated currency; state values are present-value assumptions, not targets.

| Scenario | Value per share | Status | Depends on |
|---|---:|---|---|
| Favorable economics A | 80.00 | SCENARIO_ONLY | E-01 |
| Favorable economics B | 60.00 | SCENARIO_ONLY | E-01 |
| Unfavorable economics | 20.00 | SCENARIO_ONLY | E-02 |

## What does the price require?

Price input: 40.00 · 2026-11-02T15:55:00Z · ADMISSIBLE

Each row is a separate two-state slice, not an exhaustive multi-state solution or a market probability.

| Lower-value state | Higher-value state | Price-matching higher-state weight |
|---|---|---:|
| favorable60 | favorable80 | outside this pair |
| unfavorable | favorable80 | 33.3% |
| unfavorable | favorable60 | 50.0% |

## What am I missing?

- No evidence-based event probability is available.
- Actual launch timing, financing terms and risk premia are not supplied.

## Counterevidence

- Clinical milestones do not establish regulatory approval or commercial demand.

## What would change the answer?

- Withdrawn launch-timing support invalidates dependent favorable values.
- Changed financing terms require both cash and diluted share count to be reviewed.

## Sources and assumptions

- **E-01 · assumption · admissible**: Launch timing used in both favorable scenarios is assumed, not an issuer fact.
  Published: 2026-11-01T09:00:00Z; observed: 2026-11-01T09:05:00Z; version: 1. Source: https://example.org/fictional-launch-assumption. Rights: AhaSignals synthetic fixture; MIT.
- **E-02 · assumption · admissible**: A downside state has assumed equity value of 2 billion, not a guaranteed cash floor.
  Published: 2026-11-01T09:00:00Z; observed: 2026-11-01T09:05:00Z; version: 1. Source: https://example.org/fictional-downside. Rights: AhaSignals synthetic fixture; MIT.

## Model assumptions

- Favorable economics A: Fictional equity bridge in whole USD and whole shares; operating value is already present value. No additional cash or claims in this toy case.
- Favorable economics B: Fictional equity bridge in whole USD and whole shares; operating value is already present value. No additional cash or claims in this toy case.
- Unfavorable economics: Fictional equity bridge in whole USD and whole shares; operating value is already present value. No additional cash or claims in this toy case.

## Research boundary

Scenario arithmetic is not a calibrated forecast. Price-matching weights are not real-world probabilities. NO_QUOTE: no validated probability or full cost/model-risk policy.

Two favorable assumptions and one unfavorable state are sensitivity cases, not mutually exclusive measured probabilities. Model omits risk-premium differences and detailed clinical transitions. No calibrated forecast or cost-adjusted decision margin.

AhaSignals · independent research and education only. No investment, trading, legal, tax or medical advice; no affiliation or endorsement by source owners.

Input SHA-256: `23f15422e29ea62eb910b2a8394e5d29ea663f6ae548c48fd3dc2acf638f697c`
